BioSpace News Archive

Genetown

PepGen to Participate in the Bank of America Securities 2023 Healthcare Conference

PepGen Inc. today announced that James McArthur, Ph.D., President and CEO of PepGen will present at the Bank of America Securities 2023 Healthcare Conference on Thursday, May 11th at 12:20pm EDT in Las Vegas, Nevada.

May 4, 2023
·
1 min read
Bio NC

Humacyte’s Human Acellular Vessel™ (HAV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Urgent Arterial Repair Following Vascular Trauma

Humacyte, Inc. (Nasdaq: HUMA) has been recently granted the U.S. Food and Drug Administration’s (FDA’s) Regenerative Medicine Advanced Therapy (RMAT) designation for its Human Acellular Vessel (HAV) for urgent arterial repair following extremity vascular trauma.

May 4, 2023
·
6 min read
Business

Eargo to Report First Quarter 2023 Financial Results on May 11, 2023

Eargo, Inc. today announced it will release financial results for the first quarter 2023 after market close on May 11, 2023.

May 4, 2023
·
1 min read
Genetown

CereVasc to Present Data on its Minimally Invasive CNS Delivery System at Upcoming American Society of Gene and Cell Therapy Annual Meeting

CereVasc, Inc. announced today that data on its minimally invasive Central Nervous System (CNS) Delivery System will be presented for the first time at the American Society of Gene and Cell Therapy Annual Meeting being held on May 16-20, 2023, in Los Angeles.

May 4, 2023
·
1 min read
Drug Development

Pieris Pharmaceuticals Announces Successful Completion of Safety Review for 10 mg Dose of Phase 2a Trial of Elarekibep (PRS-060/AZD1402)

Pieris Pharmaceuticals, Inc. today announced the successful safety review of the 10 mg dry powder dose safety cohort from the ongoing multi-center, placebo-controlled phase 2a study of dry powder inhaler-formulated elarekibep (PRS-060/AZD1402).

May 4, 2023
·
5 min read
Business

UroGen Pharma to Report 2023 First Quarter Financial Results on Thursday, May 11, 2023

UroGen Pharma Ltd. today announced that it will report 2023 first quarter financial results on Thursday, May 11, 2023, prior to the open of the stock market.

May 4, 2023
·
1 min read
Biotech Beach

Endologix Wins “Medical Device Engineering Breakthrough” Award in 7th Annual MedTech Breakthrough Awards Program

Endologix LLC announced that its DETOUR™ System has been selected as the winner of the “Medical Device Engineering Breakthrough” award in the 7th annual MedTech Breakthrough Awards.

May 4, 2023
·
6 min read
Harrow to Launch FDA-Approved IHEEZO™ at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Harrow (NASDAQ: HROW), a leading U.S. eyecare pharmaceutical company, today announced the launch of FDA-approved IHEEZO™ at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting being held May 5‑8, 2023, in San Diego, California.

May 4, 2023
·
4 min read
Biotech Bay

Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye

Agilent Technologies Inc. announced that Dr. Jiangbin Ye has received an Agilent Solutions Innovation Research Award.

May 4, 2023
·
3 min read
Alvotech Initiates Confirmatory Patient Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced the initiation of Alvotech’s confirmatory patient study for AVT05, a biosimilar candidate to Simponi® and Simponi Aria®.

May 4, 2023
·
8 min read